Platform and Solutions
Addressing key clinical trials challenges like a high-placebo response, heterogeneity, subjectivity and scalability.
PlaceboInsight AI
What is it
PlaceboInsightAI identifies placebo responders to increase drug-placebo differences during Phase II and III clinical trials.
Data
Validated on trial data, PlaceboInsight AI can be adapted to common end-point measurements.
Outcome
Enhances the effect size of Phase II and III clinical trials by up to 50%, directly improving their likelihood of success.
TherapyInsight AI
What is it
TherapyInsightAI utilizes EEG data to categorize patients into clusters, predicting their response to specific antidepressants within each cluster.
Data
Can be easily repurposed for novel therapies. Acts as a companion diagnostics for treatment selection and monitoring. Trained on a vast dataset, TherapyInsight AI can also facilitate drug repurposing.
Outcome
Increased likelihood of success for Phase III trials as well as improved treatment efficacy.
CleanSpectrum AI
What is it
CleanSpectrumAI cleans and combines EEG data from private, public and pharma trials datasets. Utilizes data whitening and other AI/ML models for the removal of site-related noise. Detects and filters interpolation of bad channels and removes physiological noise.
Data
The ML models have been refined using a vast dataset of 13.5 million training segments, gathered from 45 site locations and 10 different EEG devices.
Outcome
Improves the quality of EEG data in preparation for clinical trials and streamlines the overall process of data sanitation, as well as ensuring compatibility with a wide range of EEG devices.
We use diverse and hardware-agnostic data
Our rich dataset captures various patient profiles, conditions, and treatments